849 related articles for article (PubMed ID: 2410769)
1. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
2. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
Onali P; Olianas MC
Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of l-stepholidine on D2 receptor-mediated inhibition of synaptosomal adenylate cyclase in rat corpus striatum.
Hu G; Hu Y; Jin GZ
Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):104-10. PubMed ID: 1598823
[TBL] [Abstract][Full Text] [Related]
7. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
[TBL] [Abstract][Full Text] [Related]
8. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
Hensler JG; Cotterell DJ; Dubocovich ML
J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
[TBL] [Abstract][Full Text] [Related]
10. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
Barton AC; Black LE; Sibley DR
Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis.
Nisoli E; Tonello C; Memo M; Carruba MO
J Pharmacol Exp Ther; 1992 Nov; 263(2):823-9. PubMed ID: 1359119
[TBL] [Abstract][Full Text] [Related]
13. Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists.
Olianas MC; Onali P; Neff NH; Costa E
Mol Pharmacol; 1983 Mar; 23(2):393-8. PubMed ID: 6188035
[TBL] [Abstract][Full Text] [Related]
14. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
Gnegy ME; Bernabei A; Treisman G
J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
[TBL] [Abstract][Full Text] [Related]
15. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
Battaglia G; Norman AB; Hess EJ; Creese I
Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
[TBL] [Abstract][Full Text] [Related]
16. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological differences between the D-2 autoreceptor and the D-1 dopamine receptor in rabbit retina.
Dubocovich ML; Weiner N
J Pharmacol Exp Ther; 1985 Jun; 233(3):747-54. PubMed ID: 4009487
[TBL] [Abstract][Full Text] [Related]
18. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
[TBL] [Abstract][Full Text] [Related]
19. Activation of adenylate cyclase by ethanol in mouse striatal tissue.
Rabin RA; Molinoff PB
J Pharmacol Exp Ther; 1981 Jan; 216(1):129-34. PubMed ID: 7452500
[TBL] [Abstract][Full Text] [Related]
20. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
